Johansson H - Search Results

1

Impact of a surgical training programme on rectal cancer outcomes in Stockholm.

Martling A, Holm T, Rutqvist LE, Johansson H, Moran BJ, Heald RJ, Cedermark B. Martling A, et al. Among authors: johansson h. Br J Surg. 2005 Feb;92(2):225-9. doi: 10.1002/bjs.4834. Br J Surg. 2005. PMID: 15609382

2

[Therapeutic results in rectal cancer surgery. Surgical technique is of great significance].

Holm T, Johansson H, Cedermark B, Rutqvist LE, Ekelund G. Holm T, et al. Among authors: johansson h. Lakartidningen. 1997 Jun 18;94(25):2391-4. Lakartidningen. 1997. PMID: 9229661 Clinical Trial. Swedish. No abstract available.

3

[Improved therapeutic results in rectal cancer. Preoperative radiotherapy and continuing education of the surgeons is efficient].

Holm T, Cedermark B, Johansson H, Singnomklao T, Rutqvist LE. Holm T, et al. Among authors: johansson h. Lakartidningen. 2000 Aug 23;97(34):3582-6. Lakartidningen. 2000. PMID: 11036377 Clinical Trial. Swedish.

4

Tumour location and the effects of preoperative radiotherapy in the treatment of rectal cancer.

Holm T, Johansson H, Rutqvist LE, Cedermark B. Holm T, et al. Among authors: johansson h. Br J Surg. 2001 Jun;88(6):839-43. doi: 10.1046/j.0007-1323.2001.01789.x. Br J Surg. 2001. PMID: 11412255 Clinical Trial.

5

The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study.

Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B; Stockholm Colorectal Cancer Study Group. Martling A, et al. Among authors: johansson h. Cancer. 2001 Aug 15;92(4):896-902. doi: 10.1002/1097-0142(20010815)92:4<896::aid-cncr1398>3.0.co;2-r. Cancer. 2001. PMID: 11550163 Clinical Trial.

6

The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer.

Martling A, Cedermark B, Johansson H, Rutqvist LE, Holm T. Martling A, et al. Among authors: johansson h. Br J Surg. 2002 Aug;89(8):1008-13. doi: 10.1046/j.1365-2168.2002.02151.x. Br J Surg. 2002. PMID: 12153626

7

Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial.

Pettersson D, Glimelius B, Iversen H, Johansson H, Holm T, Martling A. Pettersson D, et al. Among authors: johansson h. Br J Surg. 2013 Jun;100(7):969-75. doi: 10.1002/bjs.9117. Epub 2013 Apr 2. Br J Surg. 2013. PMID: 23553796 Clinical Trial.

8

Preoperative treatment selection in rectal cancer: a population-based cohort study.

Elliot AH, Martling A, Glimelius B, Nordenvall C, Johansson H, Nilsson PJ. Elliot AH, et al. Among authors: johansson h. Eur J Surg Oncol. 2014 Dec;40(12):1782-8. doi: 10.1016/j.ejso.2014.08.481. Epub 2014 Sep 16. Eur J Surg Oncol. 2014. PMID: 25260598

9

Time to local recurrence as a prognostic factor in patients with rectal cancer.

Westberg K, Palmer G, Johansson H, Holm T, Martling A. Westberg K, et al. Among authors: johansson h. Eur J Surg Oncol. 2015 May;41(5):659-66. doi: 10.1016/j.ejso.2015.01.035. Epub 2015 Feb 19. Eur J Surg Oncol. 2015. PMID: 25749391

10

Impact of pre-treatment patient-related selection parameters on outcome in rectal cancer.

Elliot AH, Martling A, Glimelius B, Johansson H, Nilsson PJ. Elliot AH, et al. Among authors: johansson h. Eur J Surg Oncol. 2016 Nov;42(11):1667-1673. doi: 10.1016/j.ejso.2016.05.020. Epub 2016 Jun 2. Eur J Surg Oncol. 2016. PMID: 27318529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,467 results

Search Page

Filters